Literature DB >> 29132527

Irritable Bowel Syndrome: Epidemiology, Pathophysiology, Diagnosis, and Treatment.

Dean Nathanial Defrees1, Justin Bailey2.   

Abstract

Irritable bowel syndrome is a common medical condition that significantly alters patient quality of life and presents a series of diagnostic and treatment challenges to the treating provider. This article provides an updated and straightforward overview of the disease, its pathophysiology, diagnosis, and treatment options.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  IBS; Irritable bowel syndrome; Rome IV

Mesh:

Substances:

Year:  2017        PMID: 29132527     DOI: 10.1016/j.pop.2017.07.009

Source DB:  PubMed          Journal:  Prim Care        ISSN: 0095-4543            Impact factor:   2.907


  42 in total

1.  Adjunctive treatment with probiotics partially alleviates symptoms and reduces inflammation in patients with irritable bowel syndrome.

Authors:  Haiyan Xu; Chen Ma; Feiyan Zhao; Ping Chen; Yahua Liu; Zhihong Sun; Lihong Cui; Lai-Yu Kwok; Heping Zhang
Journal:  Eur J Nutr       Date:  2020-11-22       Impact factor: 5.614

2.  NaV1.1 inhibition can reduce visceral hypersensitivity.

Authors:  Juan Salvatierra; Joel Castro; Andelain Erickson; Qian Li; Joao Braz; John Gilchrist; Luke Grundy; Grigori Y Rychkov; Annemie Deiteren; Rana Rais; Glenn F King; Barbara S Slusher; Allan Basbaum; Pankaj J Pasricha; Stuart M Brierley; Frank Bosmans
Journal:  JCI Insight       Date:  2018-06-07

3.  Cohort Profile: The Christchurch IBS cOhort to investigate Mechanisms FOr gut Relief and improved Transit (COMFORT).

Authors:  Phoebe Heenan; Rob H Creemers; Shriya Sharma; Jacqueline Keenan; Simone Bayer; Wayne Young; Janine Cooney; Kelly Armstrong; Karl Fraser; Paula M Skidmore; Nicholas J Talley; Nicole Roy; Richard B Gearry
Journal:  Inflamm Intest Dis       Date:  2020-07-08

4.  Effect of probiotics and dietary fiber combined with pinaverium bromide on intestinal flora in patients with irritable bowel syndrome.

Authors:  Han Sun; Xueting Li; Weixu Chen; Fangyuan Jia; Jing Su; Bao Zhang; Xia Wu; Ping Wu
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

Review 5.  Dietary Modification for the Restoration of Gut Microbiome and Management of Symptoms in Irritable Bowel Syndrome.

Authors:  Andrew Thomas; Annie Thomas; Madeline Butler-Sanchez
Journal:  Am J Lifestyle Med       Date:  2021-05-10

Review 6.  Microscopic colitis in older adults: impact, diagnosis, and management.

Authors:  Istvan Fedor; Eva Zold; Zsolt Barta
Journal:  Ther Adv Chronic Dis       Date:  2022-07-05       Impact factor: 4.970

7.  Serum resolvin D1 levels as a marker of inflammation in constipation dominant irritable bowel syndrome.

Authors:  Eylem Karatay; Özlem Gül Utku
Journal:  Turk J Gastroenterol       Date:  2020-02       Impact factor: 1.852

Review 8.  Fecal Microbial Transplantation for Diseases Beyond Recurrent Clostridium Difficile Infection.

Authors:  Geert R D'Haens; Christian Jobin
Journal:  Gastroenterology       Date:  2019-06-17       Impact factor: 22.682

9.  Associations between chronotype, social jetlag, and weekday sleep in women with irritable bowel syndrome.

Authors:  Pei-Lin Yang; Robert L Burr; Horacio O de la Iglesia; Diana T Buchanan; Teresa M Ward; Carol A Landis; Margaret M Heitkemper
Journal:  Chronobiol Int       Date:  2021-02-22       Impact factor: 2.877

10.  Irritable Bowel Syndrome: Prevalence and Risk Factors in Jazan Region, Saudi Arabia.

Authors:  Abdulelah M Arishi; Erwa E Elmakki; Othman M Hakami; Omar M Alganmy; Sultan M Maashi; Hamood K Al-Khairat; Yasir A Sahal; Abdulaziz A Sharif; Mohammed H Alfaifi
Journal:  Cureus       Date:  2021-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.